Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Monique Aliaga"'
Autor:
Denis Ardid, Monique Aliaga, Adrian Newman-Tancredi, Mathieu Meleine, Ronan Depoortère, Emilie Muller, Laurent Bardin
Publikováno v:
European Journal of Pharmacology. 672:83-87
The role of antidepressants in the treatment of visceral pain has not been extensively examined. Milnacipran, a serotonin/noradrenalin reuptake inhibitor, has recently been approved in the USA for fibromyalgia, a chronic pathology characterized by di
Publikováno v:
European Journal of Pharmacology. 514:121-130
We studied the effects of the high-efficacy 5-hydroxytryptamine1A (5-HT1A) receptor agonist, F 13640 on both formalin-induced spinal cord c-Fos protein expression and pain behaviours in the rat. Replicating earlier data, F 13640 (0.63 mg/kg, i.p.; t(
Autor:
Adrian Newman-Tancredi, Olivier Vitton, S. Gregoire, N. Malfetes, Laurent Bardin, Philippe Ladure, Monique Aliaga, Ronan Depoortère
Publikováno v:
Neuroscience research. 66(2)
Milnacipran and duloxetine, serotonin/noradrenalin reuptake inhibitors, and pregabalin, a alpha(2)-delta(1) Ca(2+) channel blocker, are efficacious against fibromyalgia, a condition characterized by diffuse chronic pain and associated with stress. We
Autor:
Erika Abrial, Monique Aliaga, Adrian Newman-Tancredi, Laurent Bardin, Michael Rodrigues, Ronan Depoortère
Publikováno v:
Behavioural pharmacology. 20(4)
Dopamine (DA) is implicated in penile erection (PE) and yawning (YA) in rats through activation of D2-like receptors. However, the exact role of each subtype (D2, D3 and D4) of this receptor family in PE/YA is still not clearly elucidated. We recorde
Autor:
Michèle Barbara, Elisabeth Carilla-Durand, Marie-Bernadette Assié, Laurent Bardin, Mireille Maraval, Nathalie Malfètes, Adrian Newman-Tancredi, Monique Aliaga
Publikováno v:
European journal of pharmacology. 592(1-3)
Several novel antipsychotics activate serotonin 5-HT1A receptors as well as antagonising dopamine D2/3 receptors. Such a pharmacological profile is associated with a lowered liability to produce extrapyramidal side effects and enhanced efficacy in tr